Diagnóstico bioquímico de la isquemia coronaria aguda

Medicina Clinica

Volumn 115, Issue 17, 2000, Pages 671-676

  Galán Ortega, Amparo ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Acute coronary ischemia; Acute myocardial infarction; Cardiac marker; CKMB mass; MB isoforms; Myoglobin; Troponin I; Troponin T; Unstable angina

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; ISOENZYME; MYOGLOBIN; TROPONIN I; TROPONIN T;

BLOOD; ENZYMOLOGY; HEART MUSCLE ISCHEMIA; HUMAN; METABOLISM; REVIEW; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; TIME;

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; HUMANS; ISOENZYMES; MUSCLE, SKELETAL; MYOCARDIAL ISCHEMIA; MYOGLOBIN; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 0034684547     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71656-3     Document Type: Article

References (46)

1. Report of the Joint International Society and Federation of Cardiology/World Health Organizafon Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59: 607-609.
2. Panteghini M. IFCC Committee on standardization of markers of cardiac damage: premises and project presentation. IFCC. Scientific Division Committee o standardization of markers of cardiac, damage. Clin Chem Lab Med 1998; 36: 887-893.
3. Wu AHB, Apple FS, Gibier WB, Jesse RL, Warshaw MM, Valdes R. National academy of clinical biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-1121.
4. Panteghini M, Apple FS, Christenson RH, Dad F, Mair J, Wu AH. Use of biochemical markers n acute coronary syndromes. IFCC. Scientific Division. Committee on standardization of markers of cardiac damage. Clin Chem Lab Meet 1999: 37: 687-693.
5. Hearse DJ. Cellular damage during myocardial ischaemia metabolic changes leading to enzyme leakage. En: Hearse DJ. De Leins J, editores. Enzymes in cardiology. Diagnosis and research. Chichester: Wiley, 1979; 4-14.
6. Dawson DM, Fine IH. Creatine kinase n human tissues. Arch Neurol 1967; 16: 175-178.
7. Burger A, Richterch R, Aehi N. Die heterogemal der kreatin-kinase Biochem Z 1964; 339: 305-307.
8. Ryan W, Karliner JS, Gilpin EA. The creatine kinase curve area and peak creatine kinase after myocardial infarction: usefulness and limitations. Am Heart J 1981; 101: 162-168.
9. Bernstein LH, Sachs E, Jonas A. Timed sequential measurements of crealine kinase MB in diagnosis of myocardial infarction. Clin Chem 1984; 30: 1588-1589.
10. Galán A. Creatina quinasa. En: Isoenzimas y formas multiples de las enzimas en bioquimica clinica F. Canalias. 1996: 5: 33-42.
11. Mair J. Progress in myocardial damage detection: new biochemical markets for clinicians. Crit Rev Clin Lab Sci 1997; 34: 1-66.
12. Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol 1995; 104: 472-476.
13. Woo J, Lacbawan FL, Sunheimer R. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? Am J Clin Path 1995; 103: 725-729.
14. Brogan GX, Friedman S, McCuskey C. Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out myocardial infarction in the emergency department. Ann Emerg Med 1994; 24: 665-671.
15. Tucker JF, Collies RA, Anderson AJ. Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med 1994; 24: 704-708.
16. Panteghini M. Standardization activities of markers of cardiac damage: the need of a comprehensive approach. Eur Heart J 1998; 19 (Supl N): 8-11.
17. Bhayana V, Henderson AR Biochemical markers of mycoardial damage. Clin Biochem 1885; 28: 1-29.
18. Henderson AR, Krishnan S, Webb S, Cheung CM, Nazir DJ, Richardson H Proficiency testing of creatine kinase and creatine kinase-2: the experience of the Ontario Laboratary Proficiency Testing Program. Clin Chem 1998; 44: 124-133.
19. Galan A, Balsells R, Ferragut FJ, Gella FJ, Gubern G, Padros A et al. Recomendaciones para la determinacion de isoenzimas de la creating quinasa en suero sanguineo humano. Sociedad Española de Quimica Clinica y Patologia Molecular, Comite Ciertifico, Comision de Enzimas. Quim Clin 1996; 15: 53-56.
20. Douezi H, Galan A, Corominas A, Assay of CK-MB mass: analytical and clinical study. Quim Clin 1990; 9: 293.
21. Gibier WB. Lewis LM, Erb RE. Early detection of acute myocardial infarction in patients presenting with chest pain and non-diagnostic electrocardiograms: serial CK-MB sampling in the emergency department Ann Emerg Med 1990; 19: 1359-1366.
22. Galán A, Canalias F, Padres A, Sierra C, Elaboratión de un material estabe para la isoenzima MB de la creatina quinasa humana. Rev Dag Biol 1996; 159-163.
23. Gella FJ, Frey E, Ceriotti F, Galan A, Hadjivassiliou AG, Horder M et al. Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608). Clin Chim Acta 1998; 276: 35-52.
24. Stein W, Bohner J, Eggstein M, Lang H. Creatine kinase var ants Report on the workshop conference of the German Society for Clinical Chemistry. Tübingen 1982 September 19-21. J Clin Chem Clin Biochem 1983; 21: 859-876.
25. Wevers RA, Delsing M, Klein Gebbing JAG, Soons JBJ. Post-synthetic changes in the creatine kinase isoenzymes. Clin Chim Acta 1978; 86: 323-326.
26. Puleo PR, Guadagno P, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase. Clin Chem 1989; 35: 1452-1455.
27. Wu AHB, Wang XM, Gornet TG, Oradóñez-Llanos J, Creatine kinase isoforms in patients with skeletal muscle injury: ramifications for eary detection of acute myocardial infarction Clin Chem 1992; 38; 2396-2400.
28. Christenson RH, Ohman EM, Clemmensen P, Grande P, Toifaletti J, Silverman LM et al. Characteristics of creatine and MB isoforms in serum after reperfusion in acute myocardial infarction. Clin Chem 1989; 35: 2179-2185.
29. Puleo PR, Perryman B. Non invasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms. J Am Coll Cardiol 1991; 17: 1047-1052.
30. Wu AHB. Creatine kinase isoforms in ischemic heart disease. Clin Chem 1989; 35; 7-13.
31. Grace AM, Strauss AW, Sobel BE. Sensitive quantification of isoforms of canine MM creatine kinase with an immunoblot procedure suitable for large number of samples. Anal Biochem 1985; 26: 457-462.
32. Panteghini M. Serum isoforms of creatine kinase isoenzymes. Clin Biochem 1988; 21: 211-218.
33. Nohara R, Sobel BE, Abendschein DR. Quanlitative analysis of isoforms of MM creatine kinase in plasma by chromotofocusing with on-line monitoring of enzyme activity. Clin Chem 1988; 34: 235-239.
34. Escobar R, Gornet TG, Wu AHB. Evaluation of an automated electrophoresis analyzer for cardiac isoenzymes: The Helena Rep. Clin Chem 1988; 33: 1284-1288.
35. Bucher EA, Maisonpierre PC, Konieczny SF, Emerson CP. Expression of troponin complex genes: transcriptional coactivation furing myoblast differentiation and independent control in heart and skeletal muscles. Moll Cell Biol 1988; 41: 34-42.
36. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartimentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 1360-1367.
37. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarction by croatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 43: 1291-1295.
38. Wu AHB. Use of cardiac markers as assessed by outcome analysis. Clin Biochem 1997; 30: 339-350.
39. Hamm CW, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
40. Hamm CW, Goldman BU, Heeschen C. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin I or troponin T. N Engl J Med 1997; 337: 1648-1653.
41. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm AW et al. Cardiac troponin levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1312-1349.
42. Antman EM, Tanasijevic MJ, Thompson B, Schacman M, McCabe CH. Cannon CP et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndrome;. N Engl J Med 1996; 335: 1333-1341.
43. Henderson AR. An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations. Clin Lab Med 1997; 17: 625-654.
44. th ed.). Filadelfia: Saunders. 1997; 1-10.
45. Jesse RL, Kontos MC. Evaluation of chest pain in the emergency department, Curr Probl Cardiol 1997; 4: 149-236.
46. Dati F, Panteghini M, Apple FS, Chnstenson RH, Mair J, Wu AH. Proposals from the IFCC Committee on standardization of markers of cardiac damage: (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scand J Clin Lab Invest 1999; 59 (Supl 230): 113-123.